Evaxion Biotech AS Financial Flexibility Index
Evaxion Biotech AS financial flexibility index. Evaxion Biotech AS (EVAX) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of $-6.63 Million (operating CF $-6.65 Million minus capex $11.03K) represents -1% of total liabilities ($11.37 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Evaxion Biotech AS (2018–2025)
Financial flexibility index of Evaxion Biotech AS from 2018 to 2025. Historical Financial Flexibility Index trend for Evaxion Biotech AS across 8 annual periods. Explore Evaxion Biotech AS (EVAX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Evaxion Biotech AS Financial Flexibility Index by Year (2018–2025)
Evaxion Biotech AS financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Evaxion Biotech AS. For the full cash flow conversion analysis, see cash efficiency ratio of Evaxion Biotech AS.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.58x | $-6.63 Million | $-6.65 Million | $11.37 Million | ▲ +36.2% |
| 2024 | -0.92x | $-12.94 Million | $-12.94 Million | $14.14 Million | ▲ +8.4% |
| 2023 | -1.00x | $-17.60 Million | $-17.69 Million | $17.62 Million | ▲ +46.2% |
| 2022 | -1.86x | $-25.48 Million | $-25.77 Million | $13.72 Million | ▲ +30.3% |
| 2021 | -2.66x | $-20.57 Million | $-21.93 Million | $7.73 Million | ▼ -8.9% |
| 2020 | -2.44x | $-12.04 Million | $-12.44 Million | $4.93 Million | ▲ +39.6% |
| 2019 | -4.04x | $-6.96 Million | $-7.03 Million | $1.72 Million | ▼ -1825.3% |
| 2018 | -0.21x | $-1.98 Million | $-1.99 Million | $9.44 Million | — |